1Manicone AM,McGuire JK.Matrix metalloproteinases as modulators of inflammation[J].Semin Cell Dev Biol,2008,19:34-41.
2del Zoppo GJ,Milner R,Mabuchi T,et al.Microglial activation and matrix protease generation during focal cerebral ischemia[J].Stroke,2007,38:646-651.
3Pfefferkom T,Rosenberg GA.Closure of the blood-brain barrier by matrix metalloputeinase inhibition reduces rtPA mediated mortality in cerebral ischemia with delayed reperfusion[J].Stroke,2003,34:2025-2030.
4Van Lint P,Libert C.Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation[J].J Leukoc Biol,2007,82:1375-1381.
5McCawley LJ,Matrisian LM.Matrix metalloproteinases:they're not just for matrix anymore[J].Curr Opin Cell Biol,2001,13:534-540.
6Matsumoto K,Minamitani T,Orba Y,et al.Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway[J].ExpCell Res,2004,297:404-414.
7Nagase H.Activation mechanisms of matrix metalloproteinases[J].Biol Chem,1997,378:151-160.
8Mott JD,Werb Z:Regulation of matrix biology by matrix metalloproteinases[J].Curr Opin Cell Biol,2004,16:558-564.
9Wassenaar A.CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts[J].Clin Exp Immunol,1999,115:161-167.
10Mira E,Lacalle RA,Buesa JM,et al.Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface[J].J Cell Sci,2004,117:1847-1857.
2Rosenberg GA,Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia[J].Neurosurgical Focus,2007.4.
3Leonardo CC,Hall AA,Collier LA. Inhibition of gelatinase activity reduces neural injury in an exvivo model of hypoxia-ischemia[J].Neuroscience,2009,(04):755-766.
